FDA Archives - Page 52 of 220

1 minute read

Hoth Therapeutics Receives Protocol Approval For HT-001 Cancer Therapeutic; FDA Approved Trial Now Has Two Sites Approved With Additional Sites In Approval Process

July 19, 8:05 AM

FDA Approved Trial Now Has Two Sites Approved with Additional Sites in Approval Process Recruitment of Patients to Accelerate NEW YORK, July 19, 2023 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ:HOTH), a

HOTH

2 minute read

Compatibility Of Psilocybin & SSRIs For Depression, COMPASS Looks At ‘Psychedelic-Assisted Therapies’

By Lara Goldstein

July 18, 3:54 PM

COMPASS Pathways (NASDAQ: CMPS) shared results from an open-label Phase 2 trial assessing its synthetic psilocybin COMP360 alongside SSRIs for Treatment-Resistant Depression (TRD.)

CMPS

2 minute read

Medtronic Recall Certain Heart Failure Devices Citing Risk Of Low, No Energy Output During High Voltage Therapy

By Vandana Singh

July 18, 12:44 PM

Medtronic Plc (NYSE: MDT) has

MDT

1 minute read

Why Are Karyopharm Therapeutics Shares Gaining Today?

By Vandana Singh

July 18, 9:12 AM

Karyopharm Therapeutics Inc (NASDAQ: KPTI) shares are trading higher after the FDA granted Fast Track Designation to the development program of selinexor for myelofibrosis, including primary myelofibrosis, post-essential thrombocythemia myelofibrosis, and post-

KPTI

1 minute read

AstraZeneca-Sanofi’s Respiratory Syncytial Virus Treatment Scores FDA Approval To Prevent Infection In Infants

By Vandana Singh

July 18, 9:07 AM

The FDA approved AstraZeneca Plc (NASDAQ:

AZN

2 minute read

What’s Going On With Meta Stock Monday?

By Anusuya Lahiri

July 17, 11:32 AM

Meta Platforms, Inc (NASDAQ: META) stock is trading lower Monday amid reports of possible penalty from Norway regulator for

‘Quidel Cardiovascular Inc. Recalls Quidel Triage Cardiac Panels For Risk Of False Negative Troponin Results That Could Cause Delayed Diagnosis Or Missed Myocardial Infarction’

By Happy Mohamed

July 17, 9:06 AM

https://www.fda.gov/medical-devices/medical-device-recalls/quidel-cardiovascular-inc-recalls-quidel-triage-cardiac-panels-risk-false-negative-troponin-results The FDA has identified this as a Class I recall, the

QDEL

2 minute read

FDA Approves Gilead’s Remdesivir For COVID-19 Treatment Patients With Severe Renal Impairment

By Vandana Singh

July 14, 11:23 AM

The FDA approved Gilead Sciences Inc's (NASDAQ: GILD) supplemental new drug application for using Veklury (remdesivir) in COVID-19 patients with severe renal impairment,

GILD

2 minute read

Nutriband Increases Existing Credit Line To $5M Supporting The Continued Development Of Its AVERSA Platform Towards FDA Submission

By Happy Mohamed

July 14, 9:21 AM

https://nutriband.com/news/nutriband-increases-existing-credit-line-to-5-million-usd-supporting-the-continued-development-of-its-aversa-platform-towards-fda-submission Company targeting FDA submission in the first half

NTRB

3 minute read

CEL-SCI Concludes Meeting With U.S. FDA Concerning Multikine’s Approval For Head & Neck Cancer

By Happy Mohamed

July 14, 9:15 AM

FDA acknowledges the great need for improved treatments for head and neck cancer, particularly the locally advanced oral cavity that CEL-SCI is targeting and is open to a close collaboration with CEL-SCI to help

CVM